Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage.
Ajay MajorMonica PaleseEbru ErmisAnthony JamesMilena VillarroelFederico Antillon KlussmannLaila HessissenJennifer Ann GeelMuhammad Saghir KhanRashmi DalviMichael SullivanPamela R KearnsA Lindsay FrazierKathy Pritchard-JonesAkira NakagawaraCarlos Rodriguez GalindoSamuel L VolchenboumPublished in: JCO global oncology (2022)
There cannot be a one-size-fits-all approach to increasing collaboration between international pediatric cancer clinical trial groups, as this requires a nuanced understanding of local stakeholders and resources necessary to form partnerships. Needs assessments, performed either by local consortia or in conjunction with international partners, have generated productive clinical trial infrastructure. To achieve the goals of the Global Initiative for Childhood Cancer, global partnerships must be sufficiently granular to account for the distinct needs of each collaborating group and should incorporate grassroots approaches, robust twinning relationships, and implementation science.
Keyphrases
- clinical trial
- childhood cancer
- quality improvement
- young adults
- phase ii
- global health
- double blind
- open label
- study protocol
- primary care
- healthcare
- phase iii
- public health
- palliative care
- papillary thyroid
- randomized controlled trial
- high resolution
- squamous cell carcinoma
- mass spectrometry
- hiv infected
- high density
- placebo controlled
- hiv testing
- men who have sex with men